- Asthma inhalers contribute to global warming?
- Three reasons you may not be able to get the generic drug you need.
- Republicans don’t want another fight over Obamacare. Too bad, it desperately needs reform.
- “The United States is not a manufacturing backwater…. The country has the second-largest share of manufacturing output – 15.9 percent – trailing only China at 31.6 percent.
- Washington DC now has the country’s richest rich people.
Category: Drug Prices & Regulations
Wednesday Links
- “If you like your doctor, you can keep your doctor.” Here is what that means today if you are covered by Centene, the largest provider of Obamacare insurance in the country.
- Why the British economy is stagnating: “It is difficult to build almost anything, anywhere.”
- Most anti-smoking drugs don’t work and the drug companies aren’t anxious to develop new ones. Overly strict FDA regulations are partly to blame. (STAT News)
- New York’s Covid tsar spent the pandemic preaching social distancing while attending raves and sex parties.
- “Healthcare is a centrally controlled market. It is both a monopoly—sole control of supply—and a monopsony—single determinant of demand.”
Price Competition in the Drug Market
Years ago, I wrote about two very costly prescription drugs, both made from cheap, over the counter ingredients for The Health Care Blog. I also wrote a 2-page brief analysis explaining how to make your own version for a 99% discount. At the time, around 2015, a daily dose of Vimovo (Aleve and Nexium) or Duexis (ibuprofen and Pepcid) cost around $100, or about $3,000 a month.
Indian Drug Makers Busted for Concealing Poor Quality
There is a lot more to FDA compliance than what I’ve written. I have tried to explain in less than a paragraph what quality engineers spend their entire careers trying to learn. Virtually all drug and medical device manufacturers hire consultants to help them meet U.S. Food and Drug Administration (FDA) guidelines.